MRI-based radiomic features for identifying recurrent prostate cancer after proton radiation therapy

CONCLUSIONS: Our proof-of-concept study demonstrates the potential of using radiomic features as part of the differential diagnosis of PCa on mpMRI following proton therapy. The results need to be validated in a larger cohort.PMID:38409947 | DOI:10.1002/acm2.14293

Source: Clinical Prostate Cancer - February 27, 2024 Category: Cancer & Oncology Authors: Kazim Z Gumus Samuel Serrano Contreras Mohammed Al-Toubat Ira Harmon Mauricio Hernandez Savas Ozdemir Sindhu Kumar Nurcan Yuruk Mutlu Mete K C Balaji Mark Bandyk Dheeraj R Gopireddy Source Type: research